Abstract
Background: Diabetes affected 171 million people worldwide one and a half decades ago, and 366 million people are expected by 2030. The relationship between glycated hemoglobin (HbA1c) and diabetes complications was established, emphasizing the importance of good glycemic management. However, due to its high cost, the HbA1c test is considered to be not affordable or not available. The high incidence of diabetes mellitus (DM) and its more risky comorbidities in most populations necessitate the requirement for regarding an alternative test.
Objective: The aim of the current study was to assess if there is a relationship between HbA1c and random glucose levels in DM patients.
Subjects and Methods: The current study was a cross-sectional study that comprised 106 known type 1 and type 2 diabetic patients. Participants were regarded as having good glycemic control when HbA1c < 8%, whereas those with HbA1c ≥8% were regarded as having uncontrolled diabetes.
Results: Correlation analyses revealed significant direct correlations between HbA1c and RBG (r = 0.47, P<0.01).
Conclusions: RBG was directly correlated with HbA1c and may be utilized to indicate glycemic control in patients with DM when the accessible to HbA1c test is difficult or not available.
Recommended Citation
Abdul-Husseein, Hajir Karim; Watife, Abeer Tariq; Abdul-Husseein, Mustafa Karim; Al-Hindy, Hayder Abdul-Amir Makki; and Al- Akkam, Karam Akram
(2024)
"Random blood glucose as an alternative to glycated hemoglobin for assessing glycemic control in diabetes mellitus patients. Cross-sectional study in Babylon province, Iraq,"
Maaen Journal for Medical Sciences: Vol. 3
:
Iss.
4
, Article 9.
Available at: https://doi.org/10.55810/2789-9136.1065
References
[1] Mousa Mazin J, Saffar Hayder Sabeeh Al, Al-Hindy Hayder Abdul-Amir Maki. Low level laser (biophotomodulation) therapy for the treatment of diabetic foot ulcers with 532 nm KTP laser induces wound healing, fibroblast proliferation and over-expression of TGF-b. SRP 2020;11(6):396e403. https://doi.org/10.31838/srp.2020.6.63.
[2] Al-Joda BM, Al-Hindy HA-AM, Mousa MJ. Exploring the role of vitamin D2, parathyroid hormone, and C-peptides as biomarkers in diabetic neuropathy development. Med J Babylon 2024. https://doi.org/10.4103/mjbl.mjbl_1568_23.
[3] Abd-Ulhussein HK, Rizij FA. Evaluation of the effect of dapagliflozin on atherosclerosis progression by interfering with inflammatory and oxidative stress pathways in rabbits. Med J Babylon 2019;16:20e4. https://doi.org/10.4103/MJBL. MJBL_104_18.
[4] Schnell O, Crocker JB, Weng J. Impact of HbA1c testing at point of care on diabetes management. J Diabetes Sci Technol 2017;11(3):611e7. https://doi.org/10.1177/1932296816678263. 222 MA'AEN JOURNAL FOR MEDICAL SCIENCES 2024;3:219e223
[5] Gillery P. A history of HbA1c through clinical chemistry and laboratory medicine. Clin Chem Lab Med 2013;51(1):65e74. https://doi.org/10.1515/cclm-2012-0548.
[6] Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329(14): 977e86. https://doi.org/10.1056/NEJM199309303291401.
[7] UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352(9131):837e53.
[8] Lian J, Liang Y. Diabetes management in the real world and the impact of adherence to guideline recommendations. Curr Med Res Opin 2014;30(11):2233e40. https://doi.org/10. 1185/03007995.2014.
[9] American Diabetes Association. Standards of medical care in diabetesd2016. Diabetes Care 2016;39(suppl 1):S1e112.
[10] Ryden L, Grant PJ, Anker SD, Berne C, Cosentino F, Danchin N, et al. ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: the Task Force on diabetes, prediabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and developed in collaboration with the European Association for the Study of Diabetes (EASD). Eur Heart J 2013;34(39):3035e87. https://doi.org/10.1093/ eurheartj/eht108.
[11] Kazmi NHS, Gillani S, Afzal S, Hussain S. Correlation between glycated haemoglobin levels and random blood glucose. J AyubMed Coll Abbottabad 2013;25(1e2):86e8.
[12] Sidorenkov G, Haaijer-ruskamp FM, de ZeeuwD, Denig P. A longitudinal study examining adherence to guidelines in diabetes care according to different definitions of adequacy and timeliness. PLoS One 2011;6(9):e24278. https://doi.org/ 10.1371/journal.pone.0024278.
[13] Ul-Ain Q, Latif A, Jaffar SR, Ijaz A. Evaluation of random plasma glucose for assessment of glycaemic control in type 2 diabetes mellitus. J Pakistan Med Assoc 2017;67(9):1353e6.
[14] Leino A, Turpeinen U, Koskinen P. Automated measurement of 25-OH vitamin D3 on the Roche Modular E170 analyzer. Clin Chem 2008;54:2059e62. https://doi.org/10.1373/clinchem.2008.111732.
[15] Alkhatatbeh MJ, Abdul-Razzak KK. Association between serum 25-hydroxyvitamin D, hemoglobin A1c and fasting blood glucose levels in adults with diabetes mellitus. Biomed Rep 2018;9(6):523e30. https://doi.org/10.3892/br.2018.1159.
[16] Asgharzadeh M, Pourasghary S, Pourasghary B, Nourazarian M, Kafil HS. Effective factors in controlling diabetes progression among patients in the northwest of Iran. J Nat Sci Biol Med 2016;7(1):68e71. https://doi.org/10. 4103/0976-9668.175075.
[17] Bowen ME, Xuan L, Lingvay I, Halm EA. Random blood glucose: a robust risk factor for Type2 diabetes. J Clin Endocrinol Metab 2015;100(4):1503e10. https://doi.org/10. 1210/jc.2014-4116.
[18] Sikaris K. The correlation of hemoglobin A1c to blood glucose. J Diabetes Sci Technol 2009;3(3):429e38. https://doi. org/10.1177/193229680900300305.
[19] Hershon KS, Hirsch BR, Odugbesan O. Importance of postprandial glucose in relation to A1C and cardiovascular disease. Clin Diabetes 2019;37(3):250e9. https://doi.org/10.2337/ cd18-0040.
[20] Båvenholm PN, Efendic S. Postprandial hyperglycaemia and vascular damage: the benefits of acarbose. Diabetes Vasc Dis Res 2006;3:72e9. https://doi.org/10.3132/dvdr.2006.017.
[21] Rasmussen JB, Nordin LS, Rasmussen NS, Thomsen JA, Street LA, Bygbjerg IC. Random blood glucose may be used to assess long-term glycaemic control among patients with type 2 diabetes mellitus in a rural African clinical setting. TMIH 2014;19(12):1515e9. https://doi.org/10.1111/tmi. 12391.
[22] Ketema EB, Kibret KT. Correlation of fasting and postprandial plasma glucose with HbA1c in assessing glycemic control; systematic review and meta-analysis. Arch Publ Health 2015;73:43. https://doi.org/10.1186/s13690- 015-0088-6.
[23] International Diabetes Federation Guideline Development Group. Global guideline for type 2 diabetes. Diabetes Res Clin Pract 2014;104(1):1e52. https://doi.org/10.1016/j.diabres. 2012.10.00.
[24] Bleyer AJ, Hire D, Russell GB, Xu J, Divers J, Shihabi Z, et al. Ethnic variation in the correlation between random serum glucose concentration and glycatedhaemoglobin. Diabet Med 2009:26e12833. https://doi.org/10.1111/j.1464-5491.2008.02646.x.
[25] Gill GV, Hardey KJ, Patrick AW, Masterson A. Random blood glucose estimation in type 2 diabetes: does it reflect overall glycaemic control? Diabet Med 1994:11e7058. https:// doi.org/10.1111/j.1464-5491.1994.tb00337.x.
[26] Otieno FC, Ng'ang'a L, Kariuki M. Validity of random blood glucose as a predictor of the quality of glycaemic control by glycated haemoglobin in outpatient diabetic patients at Kenyatta National Hospital. East Afr Med J 2002:79e491. https://doi.org/10.4314/eamj.v79i9.9122
Indexed in: